Company Intelligence

WhiteLab Genomics

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

In this profile

Quick Facts

  • Founded 2022
  • Headquarters Paris, United States
  • Country United States
  • Industry AI in Healthcare
  • Company Type Growth
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Why It Matters

Unleashing the potential of DNA and RNA based therapies using AI

Recent Developments

  1. 2022 Company founded

    WhiteLab Genomics was founded in 2022 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe